Freespira for Panic Disorder & PTSD
Panic Disorder, Post-Traumatic Stress Disorder (PTSD)
ApprovedActive
Key Facts
Indication
Panic Disorder, Post-Traumatic Stress Disorder (PTSD)
Phase
Approved
Status
Active
Company
About Freespira
Freespira is a commercial-stage digital therapeutics company offering a non-medication, device-based treatment for panic attacks and PTSD. Its FDA-cleared system addresses physiological dysregulation linked to these conditions by training users to normalize their breathing and CO2 sensitivity. The company has demonstrated strong clinical results, including high rates of patients remaining panic attack-free one year post-treatment, and is now expanding its reach to adolescents. Its business model focuses on B2B partnerships with payers and providers to drive adoption.
View full company profile